Rabbit Polyclonal Antibody to Adalimumab/Humira
Adalimumab (Humira) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic psoriasis, hidradenitis suppurativa, and juvenile idiopathic arthritis. Adalimumab binds to the TNF alpha (tumor necrosis factor-alpha), and blocks its interaction with TNF alpha receptors, reducing the inflammatory response of autoimmune diseases. Anti-Adalimumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Adalimumab.
Product Specifications
Host
Rabbit
Immunogen
Adalimumab
Clonality
Polyclonal
Applications
ELISA
Purification
Antigen affinity chromatography
Format
Purified
Components
0.5 mg/mL, lyophilized with PBS, pH 7.4, containing 0.02% sodium azide.
Storage Conditions
Applications Notes
ELISA detection: 0.05-0.2 μg/mL
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items